A Measurement of Knee Osteoarthritis Usual Care
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01649518|
Recruitment Status : Completed
First Posted : July 25, 2012
Last Update Posted : June 2, 2016
Osteoarthritis is the most common affection of joints worldwide. Multiple international guidelines on the approach and treatment of knee osteoarthritis are available. Nevertheless there seems to be a gap between usual care and the preferred one.
A vigorous set of evidence-based quality indicators on osteoarthritis diagnosis and therapy was developed by a multidisciplinary expert team. This project aims to map usual care and to explore the gaps between usual care and international guidelines in a second stage. This will enable us to develop a tightly targeted quality improvement intervention later on.
|Condition or disease|
|Osteoarthritis, Knee Guideline Adherence Quality Indicators, Health Care|
|Study Type :||Observational|
|Actual Enrollment :||284 participants|
|Study Start Date :||November 2012|
|Actual Primary Completion Date :||July 2015|
- Guideline adherence measured by a number of quality indicators and presented as the percentage of patients in whom a quality indicator was reached [ Time Frame: one measurement at the point of recruitment ]Guideline adherence by physicians and physiotherapists will be measured by quality indicators. A questionnaire about the care patients received from diagnosis of knee osteoarthritis till now will be used.
- Barriers and facilitators for guideline adherence [ Time Frame: 10 years ]Barriers and facilitators for guideline adherence will be explored by focusgroup research with focusgroups of general practitioners, orthopedic surgeons and patients
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01649518
|Leuven, Belgium, 3000|